Bionano Genomics

Bionano Genomics

Life Sciences Tools & Services
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

$16.9M

Market Cap • 10/9/2026

2007

(19 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,5

P/S

1,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

2,7

EPS

—

Market Cap

Market Cap

16,9M

EV

13,7M

EV/Revenue

0,9

EV/EBITDA

-1,1

EV/EBIT

-0,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-80,4%

Total Yield

-80,4%

Payout

0%

Retained Earnings

-735,3M

Profitability

Gross Margin

44,2%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

39,6%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

39,8%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

3%

CAGR Op. Income 5Y

-19%

CAGR Net Income 5Y

-20,3%

CAGR EPS 5Y

-53,8%

CAGR OCF 5Y

-27,2%

Leverage

N.D./EBITDA

0,3

Debt/Equity

0%

Current Ratio

2,5

Quick Ratio

1,4

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium